287 related articles for article (PubMed ID: 29558894)
21. Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making.
Tu HAT; de Vries R; Woerdenbag HJ; Li SC; Le HH; van Hulst M; Postma MJ
Value Health Reg Issues; 2012 May; 1(1):7-14. PubMed ID: 29702830
[TBL] [Abstract][Full Text] [Related]
22. Economic evaluations of hepatitis B vaccination for developing countries.
Tu HA; Woerdenbag HJ; Kane S; Riewpaiboon A; van Hulst M; Postma MJ
Expert Rev Vaccines; 2009 Jul; 8(7):907-20. PubMed ID: 19538116
[TBL] [Abstract][Full Text] [Related]
23. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy A; Clark RA; Quaife M; Weerasuriya CK; Mukandavire C; Bakker R; Deol AK; Malhotra S; Gebreselassie N; Zignol M; Sim SY; Hutubessy RCW; Baena IG; Nishikiori N; Jit M; White RG; Menzies NA
PLoS Med; 2023 Jan; 20(1):e1004155. PubMed ID: 36693081
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.
Wong WW; Hicks LK; Tu HA; Pritchard KI; Krahn MD; Feld JJ; Chan KK
Breast Cancer Res Treat; 2015 Jun; 151(3):639-52. PubMed ID: 25962692
[TBL] [Abstract][Full Text] [Related]
25. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves.
Kim SY; Salomon JA; Goldie SJ
Bull World Health Organ; 2007 Nov; 85(11):833-42. PubMed ID: 18038073
[TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
Mafirakureva N; Mapako T; Khoza S; Emmanuel JC; Marowa L; Mvere D; Postma MJ; van Hulst M
Transfusion; 2016 Dec; 56(12):3101-3111. PubMed ID: 27696441
[TBL] [Abstract][Full Text] [Related]
27. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
28. Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).
La Torre G; Mannocci A; Saulle R; Colamesta V; Meggiolaro A; Mipatrini D; Sinopoli A
Hum Vaccin Immunother; 2016 Sep; 12(9):2299-311. PubMed ID: 27105443
[TBL] [Abstract][Full Text] [Related]
29. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
Lee D; Park SM
PLoS One; 2016; 11(11):e0165879. PubMed ID: 27802340
[TBL] [Abstract][Full Text] [Related]
31. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations.
Coward S; Leggett L; Kaplan GG; Clement F
BMJ Open; 2016 Sep; 6(9):e011821. PubMed ID: 27601496
[TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
34. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.
Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N
Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721
[TBL] [Abstract][Full Text] [Related]
35. Routine prenatal screening of Indian women for HBsAg: benefits derived versus cost.
Sriprakash I; Anil TP
Trop Doct; 1997 Jul; 27(3):176-7. PubMed ID: 9227020
[TBL] [Abstract][Full Text] [Related]
36. An economic analysis of adult hepatitis B vaccination in China.
Zheng H; Wang FZ; Zhang GM; Cui FQ; Wu ZH; Miao N; Sun XJ; Liang XF; Li L
Vaccine; 2015 Nov; 33(48):6831-9. PubMed ID: 26384449
[TBL] [Abstract][Full Text] [Related]
37. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review.
Erfani P; Bhangdia K; Stauber C; Mugunga JC; Pace LE; Fadelu T
Oncologist; 2021 Aug; 26(8):e1406-e1417. PubMed ID: 34050590
[TBL] [Abstract][Full Text] [Related]
38. Economics of physical activity in low-income and middle- income countries: a systematic review.
Ranasinghe PD; Pokhrel S; Anokye NK
BMJ Open; 2021 Jan; 11(1):e037784. PubMed ID: 33452186
[TBL] [Abstract][Full Text] [Related]
39. Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review.
Dahham J; Rizk R; Kremer I; Evers SMAA; Hiligsmann M
Pharmacoeconomics; 2021 Jul; 39(7):789-807. PubMed ID: 33956330
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.
Crespo J; Esteban R; Torres C; Oyagüez I; Casado MÁ; Buti M
Rev Esp Enferm Dig; 2017 Sep; 109(9):619-626. PubMed ID: 28648087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
